NCT00035373|Terminated
Loading search results
Sponsor study identifier
Secondary identifiers
observational
767
1 country
1
Study Start
April 19, 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
April 29, 2015
Date type not reportedThis date has not been verified as actual or estimated.
The objective of this study is to evaluate patients with tumors of the central nervous system (CNS) for eligibility in the National Cancer Institute s research studies. These patients will undergo a series of procedures, usually including a complete medical history and physical examination; laboratory testing of blood, CSF, urine, bone marrow, or other samples; an evaluation of tumor location and size by x-rays, CT (computed tomography) or MRI (magnetic resonance imaging) scans, or nuclear medicine scans; lumbar puncture; electrocardiogram and echocardiogram; and procedures to evaluate the function of specific organs. A bone marrow biopsy is occasionally performed. Research samples may also be collected and stored to avoid having to do a painful test more than once. Tissue specimens collected during this process may be stored and used in future studies. Patients of both genders, any age, and all racial and ethnic groups with tumors of the CNS or a history of a CNS tumor are eligible. Up to 100 people are expected to participate. The physician will discuss the results of these procedures with the patient and his or her family. On the basis of the eligibility screening and the patient s wishes, the patient may then be enrolled in a primary research protocol.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 29, 2015
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 19, 2002
Date type not reportedThis date has not been verified as actual or estimated.
May 2, 2002
Actual (reported)May 3, 2002
Actual (reported)April 29, 2015
Date type not reportedThis date has not been verified as actual or estimated.
Evaluate patients with tumors of the Central Nervous System (CNS) for eligibility in National Cancer Institute (NCI) research protocols.
Ongoing
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Katherine E Warren, M.D.
National Cancer Institute (NCI)
767 participants (actual enrollment reported by the registry).
First Submitted
May 2, 2002
First Posted
May 3, 2002
Study Start
April 19, 2002
Date type not reportedThis date has not been verified as actual or estimated.
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Contact the study team to confirm eligibility.
Study Completion
April 29, 2015
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
November 7, 2019
Record last verified: 2015-04-29
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: